BioTB
Medical Governance & E-E-A-TSTD-ED-2026.4

Clinical Editorial & Peer-Review Policy

Published by BioTBThis policy last updated Editorial policy

Healthcare decisions require uncompromising precision. At BioTB, our editorial mandate is grounded in peer-reviewed medical consensus, clinical guidelines established by institutions like ICMR and WHO, and mandatory review by board-certified specialists.

Last Updated: October 2026•Governed by: BioTB Medical Advisory Board•View Advisory Board →

1. Core Clinical Editorial Mandate

BioTB does not publish unverified wellness trends, speculative therapies, or sponsored medical articles. Every clinical guide, diagnostic explanation, and treatment overview must satisfy three immutable criteria:

01

Evidence-Based Consensus

Information must derive from randomized controlled trials (RCTs), meta-analyses, and peer-reviewed consensus statements published by recognized clinical authorities.

02

Practicing Clinician Review

Content is vetted and signed off by actively practicing specialists.

03

Commercial Independence

Zero commercial influence. No pharmaceutical manufacturer, private hospital, or doctor can pay to alter medical content or modify recommendations.

2. Authorship & Medical Review Roles

Every clinical page on BioTB, from a condition guide to a specialty explainer, passes through clearly separated roles. Nobody signs off their own work, and the person who checks the medicine is never the person who wrote the first draft.

Medical Writer

Researches the topic, builds the reference list and writes a plain-language draft for patients. The writer is responsible for every citation matching what the source actually says.

Specialist Medical Reviewer

A qualified clinician practising in the relevant specialty checks diagnosis, treatment options, dosing ranges, contraindications and red-flag symptoms, and either approves the page or returns it with required changes.

Clinical Editor

Checks that the page is readable, that claims are supported by the cited evidence, that emergency guidance is prominent, and that the page follows this policy before it goes live.

Medical Advisory Board

Sets and approves the editorial standards on this page and settles disagreements between writers and reviewers on contested clinical questions.

Each clinical page shows who reviewed it and the date it was last medically reviewed. The governance of the board itself, including how members are appointed and how their interests are declared, is described on the BioTB Medical Advisory Board page.

3. The 4-Stage Medical Editorial Workflow

Every clinical document follows an audited 4-stage publication lifecycle prior to indexing:

Stage 1

Literature Review & Clinical Drafting

Medical writers with postgraduate health science credentials analyze the latest Cochrane reviews, ICMR guidelines, PubMed citations, and specialty societies (e.g. Cardiological Society of India, Indian Chest Society).

Stage 2

Board-Certified Specialist Peer Review

A specialist physician practicing in the relevant field (e.g., DM Cardiologist for coronary disease, MS/MCh Orthopedics for joint arthroplasty) conducts line-by-line clinical verification for accuracy, dosages, safety contraindications, and emergency warnings.

Stage 3

Integrative Care Safety Audit & Fact Checking

Our clinical integrity desk validates that complementary systems (Ayurveda, Naturopathy) are strictly bounded to prevent dangerous herb-drug interactions or delay of acute emergency care.

Stage 4

Annual Clinical Audit & Schema Publishing

Articles are published with full Schema.org MedicalCondition and FAQPage structured data, stamped with a clinical audit registry number, and scheduled for mandatory recertification every 12 months.

4. AI-Assisted Content Disclosure

BioTB uses Clinical AI tools to speed up the slow parts of medical publishing: summarising long guidelines, suggesting a structure for a new guide, simplifying language, and checking a draft for missing red-flag symptoms. AI never has the final word on medical content.

Clinician review is mandatory: AI drafts are always reviewed by a qualified clinician before publication. An AI-assisted page goes through exactly the same four stages as any other page, with no shortcuts.

No machine-generated citations: every reference is opened and checked against the original source by a person. A citation that cannot be traced to a real guideline or paper is removed, along with the claim it was meant to support.

Disclosure: where AI tools materially assisted in drafting a clinical guide, the page says so alongside its review details.

Interactive tools are different: answers from BioTB Match™ clinical AI triage are generated in real time and are not reviewed line by line before you see them. They help you choose the right kind of specialist; they are not a diagnosis. The limits are set out in our medical disclaimer.

5. Evidence Hierarchy

Not all evidence carries the same weight. When sources disagree, our writers and reviewers follow this order, and a lower tier can never overrule a higher one on the same question:

Tier 1

Systematic reviews, meta-analyses and clinical practice guidelines

Cochrane reviews and guidelines from bodies such as ICMR, WHO and national specialty societies. Where an Indian guideline exists and is current, it is preferred, because it reflects local disease patterns, drug availability and cost.

Tier 2

Randomised controlled trials

Well-conducted RCTs published in peer-reviewed journals. A single trial is reported as a single trial, with its size and limits, not as settled practice.

Tier 3

Observational studies

Cohort, case-control and registry studies. Useful for risks, side effects and real-world outcomes, but we say clearly when a finding shows an association rather than cause and effect.

Tier 4

Expert opinion and consensus statements

Used only where higher-tier evidence does not exist, and labelled as expert opinion on the page.

Press releases, manufacturer marketing, testimonials and unreferenced articles are never used as evidence for a clinical claim.

6. Evidence Grading Framework

BioTB adheres to internationally standard Classes of Recommendation and Levels of Evidence adapted from the American College of Cardiology (ACC), European Society of Cardiology (ESC), and the Oxford Centre for Evidence-Based Medicine:

Class I (Strong Recommendation)

Evidence or general agreement that a given treatment or procedure is beneficial, useful, and effective. Always recommended as primary standard of care.

Class IIa (Moderate Recommendation)

Weight of evidence/opinion is in favor of usefulness/efficacy. Reasonable and appropriate for clinical adoption.

Class IIb (Weak / Conditional)

Usefulness/efficacy is less well established by evidence/opinion. May be considered in selected refractory cases.

Class III (Harm or Ineffective)

Evidence or general agreement that the treatment is NOT useful/effective and in some cases may be harmful. Strictly contraindicated.

7. Sourcing & Citation Standards

A reader should be able to check any medical statement on BioTB for themselves. Our citation rules are designed to make that possible:

Primary sources first: we cite the guideline, review or trial itself, not a news story about it. Each reference carries a link, DOI or PubMed ID wherever one exists.

Every clinical claim is sourced: statements about how common a condition is, how well a treatment works, or what a test result means are tied to a specific reference. If no adequate source exists, the claim is removed.

Currency: reviewers check that each cited guideline is the latest version. A superseded guideline is replaced, not left in place with a note.

Medicines: dosing information follows current guidelines and approved prescribing information, is given as general ranges only, and always tells the reader to follow their own doctor's prescription.

Facts about doctors, hospitals and labs follow a separate provenance standard: where each fact comes from and how often it is refreshed is documented in BioTB sources and data standards, and the checks behind the Verified badge are set out in our verification methodology.

8. Review Cadence & Content Updates

Medical content goes out of date. Condition guides are reviewed at least every 12 months, or sooner when guidelines change. An earlier review is triggered when:

A major guideline relevant to the page is published or revised, for example a new national treatment protocol.

A drug safety alert, withdrawal or new contraindication affects a medicine the page mentions.

A reader, patient or clinician reports a possible error through our corrections process.

A reviewer or board member identifies new high-quality evidence that changes the advice.

The "last reviewed" date on a page changes only when a clinician has re-checked the whole page against current evidence. Spelling fixes and layout changes do not reset it. Pages listing providers in Lucknow and Delhi NCR are refreshed on the provider-data cadence described in our data sources standard.

9. Integrative Medicine & Safety Boundaries

India possesses a rich tradition of AYUSH systems (Ayurveda, Yoga, Unani, Siddha, Homeopathy). BioTB recognizes licensed AYUSH practitioners. However, our editorial standard maintains an uncompromising clinical boundary:

Emergency & Critical Care Exclusivity: Acute life-threatening emergencies (acute coronary syndrome, ischemic stroke, severe sepsis, surgical abdomen, traumatic hemorrhage) must be managed exclusively at Level-1/2 emergency trauma and allopathic tertiary centers. BioTB prohibits recommending alternative remedies in acute triage scenarios.

Herb-Drug Interaction Audits: All integrative articles must clearly state pharmacological interaction risks (e.g. herbal coumarins interacting with modern antiplatelets, nephrotoxic risks of unpurified heavy metal bhasmas, and glycemic clashes).

Classical Evidence Standardization: Ayurvedic therapies listed on BioTB are referenced against the Ayurvedic Pharmacopoeia of India (API) and Central Council for Research in Ayurvedic Sciences (CCRAS) protocols.

10. Commercial Independence & No Pay-to-Rank Policy

BioTB operates with strict architectural segregation between commercial operations and medical editorial integrity:

The BioTB Medical Integrity Covenant:

  • Physicians, clinics, and hospital networks CANNOT pay for preferred placement, favorable editorial commentary, or higher TrustScores.
  • Verified negative reviews authenticated via valid prescription and OPD receipts CANNOT be removed or suppressed by paying fees.
  • Editorial reviewers receive fixed honoraria unrelated to page traffic, commercial click-throughs, or provider revenue.
  • Any institutional affiliation of our Medical Advisory Board members is transparently disclosed on their public profiles.

How BioTB is funded, why rankings cannot be bought, and how any commercial content would be labelled are explained in full in our advertising and independence policy. How the TrustScore™ itself is calculated is documented on the TrustScore™ index page.

11. Conflicts of Interest

A reviewer who works at a hospital, consults for a drug company or owns part of a diagnostic lab may be an excellent clinician, but readers deserve to know about it, and that interest must not shape what they read. Our rules:

Declare

Writers, reviewers and board members declare financial and professional interests in writing, including employment, ownership, consulting, speaking fees and research funding from pharmaceutical, device or healthcare companies, and update the declaration whenever it changes.

Step aside

A reviewer does not review content about a product, procedure or institution in which they have an interest. For example, a cardiologist employed by one Lucknow hospital does not review that hospital's profile or a guide that compares it with others.

No sponsored medicine

BioTB does not accept content, briefings or payment from manufacturers in exchange for coverage of a medicine, device or test, and reviewers may not accept gifts linked to their BioTB work.

12. Corrections & Clinical Errata Protocol

Medicine is constantly advancing. If a practicing clinician or researcher identifies an outdated guideline, medication dosage change, or newly published randomized trial that impacts our content, our editorial board investigates immediately.

In short: anyone can report an error; a clinical reviewer assesses every report; confirmed errors are fixed on the page and the review date is updated; and corrections that change medical meaning are noted on the page rather than made silently. Timelines, how corrections are displayed, and how doctors and hospitals can request updates to their own profiles are set out in our corrections policy.

Submit a Clinical Correction Request

Please include PMID / DOI citations and clinical rationale.

[email protected]